Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...
Diabetes mellitus could drain tens of trillions from the global economy, with informal caregiving emerging as the largest ...
A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...
People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...
Even if you’re at risk for cardiovascular disease, you still may be a candidate for keto. Check out this overview on the ...
BBO-8520 monotherapy in patients with KRASG12C non-small cell lung cancer (NSCLC) showed a 65% objective response rate (ORR) ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...
Cholesterol-lowering drugs (statins) reduce heart disease risk and death in adults with type 2 diabetes, making them a key ...
Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
A case-based, integrative strategy for addressing brain fog, executive dysfunction, and long-term cognitive risk in ...